Bridge promissory notes from B. Riley Commercial Capital
Company: Core Scientific
What the later record shows
The date slipped · new target June 1, 2023
The $60M and $15M bridge notes were entered in April 2022 as stated. In August 2022 they were amended to push the December 7, 2022 maturity out to June 1, 2023.
“In April 2022, the Company entered into a $ 60.0 million bridge promissory note with B. Riley Commercial Capital, LLC and a $ 15.0 million bridge promissory note”
2022-08-21 · Core Scientific 10-Q filed 2022-08-22 View cached copy (2026-09-13)Live source ↗
“The Amended Bridge Notes amend the original notes having identical principal amounts to extend the maturity date from December 7, 2022 to June 1, 2023.”
2022-09-07 · Core Scientific 424B3 filed 2022-09-08 View cached copy (2026-09-13)Live source ↗
Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Entered into two bridge promissory notes totaling $75 million ($60 million with B. Riley Commercial Capital, LLC and $15 million with an affiliate) maturing December 7, 2022, bearing interest at 7% per annum, amortizing in equal monthly installments starting August 1, 2022
Source (primary)
Core Scientific 8-K filed 2022-04-08 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “entered into two bridge promissory notes, one in an aggregate principal amount of $60 million with B. Riley Commercial Capital, LLC and one in an aggregate principal amount of $15 million with an affiliate of B. Riley Commercial Capital, LLC (the "Notes"). The Notes mature on December 7, 2022, bear interest at a rate of 7% per annum and amortize in equal monthly installments starting on August 1, 2022.”
How we checked this
Checked on October 11, 2026. The cited source supports every part of this claim.
The 8-K states each element of the claim: both note amounts and counterparties, the maturity date, the interest rate and the amortization schedule. The $75 million total is the sum of the two stated principal amounts.
Confirmed in the source:
- Core Scientific entered into two bridge promissory notes
- One note was for $60 million with B. Riley Commercial Capital, LLC
- One note was for $15 million with an affiliate of B. Riley Commercial Capital, LLC
- The two notes total $75 million ($60 million plus $15 million)
- The notes mature on December 7, 2022
- The notes bear interest at 7% per annum
- The notes amortize in equal monthly installments starting August 1, 2022
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522100532/d324317d8k.htm) in full (5,528 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 8-K filed 2022-04-08
Quote: “entered into two bridge promissory notes, one in an aggregate principal amount of $60 million with B. Riley Commercial Capital, LLC and one in an aggregate principal amount of $15 million with an affiliate of B. Riley Commercial Capital, LLC (the "Notes"). The Notes mature on December 7, 2022, bear interest at a rate of 7% per annum and amortize in equal monthly installments starting on August 1, 2022.”
delays Core Scientific 424B3 filed 2022-09-08
Quote: “The Amended Bridge Notes amend the original notes having identical principal amounts to extend the maturity date from December 7, 2022 to June 1, 2023.”
delays Core Scientific 10-Q filed 2022-08-22
Quote: “In April 2022, the Company entered into a $ 60.0 million bridge promissory note with B. Riley Commercial Capital, LLC and a $ 15.0 million bridge promissory note”